Skip to content
Disclosery

Founders Fund VI Management, LLC

Follow

13F filer, CIK 1853382, SAN FRANCISCO, CA

Founders Fund VI Management, LLC reported $264,157 across 3 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-24-002619

Period
2024-03-31
Reported value
$264K
Holdings
3
Top 10 weight
100%
New
2
Sold out
1

Part of the filer group Founders Fund Growth II Management, LP

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SNAPnew+9,050$104K
NVMInew+4,142$7.33K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ROIVexited-1,119,489-$12.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2024

Share positions as resolved from 13F-HR 0001085146-24-002619, largest first. % of portfolio is the value over $264,157, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CYCLO THERAPEUTICS INCCYCLO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 110,023 shares 110,023$153K57.89%0
SNAPSNAP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 9,050 shares 9,050$104K39.33%newTimeline
NVMINOVA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 4,142 shares 4,142$7.33K2.78%newTimeline

Sold out in Q1 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ROIVROIVANT SCIENCES LTD1,119,489$12.6Mshares

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-24-002619 base2024-05-15acceptance time not in the bulk data set